Gene Logic to Present at the 2005 UBS Global Life Sciences Conference

Gene Logic Inc. (NASDAQ:GLGC) announced today that Chief
Executive Officer and President Mark D. Gessler will present at the
2005 UBS Global Life Sciences Conference held at the Grand Hyatt
Hotel, New York City on Thursday, September 29, 2005. The presentation
will begin at 11:00 a.m. (ET).
   The presentation will be webcast live and can be accessed at
www.genelogic.com under Investors/Company Overview. The webcast will
be archived for 30 days following the presentation and will be
available under Investors/Webcasts.

   Gene Logic Overview

   Gene Logic is leading the transformation of pharmaceutical
research and development with its extensive gene expression databases,
pioneering efforts in toxicogenomics, sophisticated bioinformatics
expertise, specialty nonclinical testing capabilities and cutting edge
technology program for drug repositioning. Gene Logic technologies and
services are used by many of the world's top pharmaceutical and
biotechnology companies. Over 150 organizations and government
agencies have benefited from Gene Logic's diverse portfolio of drug
development services, enabling them to make more informed, more
reliable and more predictive decisions at each point in the highly
complex and costly drug development process. Founded in 1994, Gene
Logic is headquartered in Gaithersburg, Md., with additional research
and development facilities in Cambridge, Mass. and Berkeley, Calif.
The Company maintains customer support operations in Europe and Asia
and currently has about 450 employees worldwide. For more information,
visit www.genelogic.com or call toll-free - 1/800/GENELOGIC.